Lagis Enterprise Co., Ltd. (TPEX:6730)

Taiwan · Delayed Price · Currency is TWD

37.95

-1.00 (-2.57%)

Jun 18, 2026, 1:30 PM CST

-7.78% (1Y)

Market Cap	1.38B +1.0%
Revenue (ttm)	486.50M +6.5%
Net Income	67.80M +2.3%
EPS	2.00 -1.9%
Shares Out	36.30M
PE Ratio	18.96
Forward PE	n/a
Dividend	1.50 (3.95%)
Ex-Dividend Date	Jul 6, 2026

Volume	10,000
Open	38.00
Previous Close	38.95
Day's Range	37.40 - 39.20
52-Week Range	34.00 - 52.20
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Lagis Enterprise

Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China. Its products include trocars, include optical tip trocar, dilating tip trocar, shielded bladed tip trocar, blunt tip trocar, TRE trocar system, balloon trocar; single port surgery devices, include advanced single port device, single port kit for TAMIS, and advanced single port device for vNOTES; path cap and shield wound reactors; energy bipolar forceps; suction irrigation systems and ir... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2004

Employees 202

Stock Exchange Taipei Exchange

Ticker Symbol 6730

Full Company Profile

Financial Performance

In 2025, Lagis Enterprise's revenue was 487.65 million, an increase of 7.33% compared to the previous year's 454.36 million. Earnings were 69.27 million, an increase of 1.51%.

Financial Statements